For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240724:nRSX7021Xa&default-theme=true
RNS Number : 7021X Primary Health Properties PLC 24 July 2024
Primary Health Properties PLC
("PHP" or the "Company"),
Director/PDMR Shareholding
The Company has been notified that the following information relating to the
transaction detailed below has been filed with the FCA in accordance with
Article 19(1) of the Market Abuse Regulation.
1 Details of person discharging managerial responsibilities/person closely
associated
(a) Name Harry Hyman
2 Reason for notification
(a) Position/Status Non-executive Chair
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument Ordinary shares of 12.5p
ISIN: GB00BYRJ5J14
(b) Nature of the transaction Transfer of shares already owned into SIPP
(c) Price(s) and volume(s) Price(s) Volume(s)
£ 0.9255 74,890
(d) Aggregated volume price Single transaction
£63,310.70
(e) Date of transaction 24 July 2024
(f) Place of transaction London Stock Exchange (xlon)
For further information
Primary Health Properties PLC
Toby Newman, Company Secretary & Chief Legal Officer
+44(0) 7729 047 959
Legal Entity Identifier: 213800Y5CJHXOATK7X11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBXGDRGXDDGSS